- Home
- HBI vs RDY Comparison
HBI vs RDY Comparison
Compare HBI & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBI
- RDY
- Stock Information
- Founded
- HBI 1901
- RDY 1984
- Country
- HBI United States
- RDY India
- Employees
- HBI N/A
- RDY N/A
- Industry
- HBI Clothing/Shoe/Accessory Stores
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- HBI Consumer Discretionary
- RDY Health Care
- Exchange
- HBI Nasdaq
- RDY Nasdaq
- Market Cap
- HBI 2.1B
- RDY 2.1B
- IPO Year
- HBI 2006
- RDY N/A
- Fundamental
- Price
- HBI $5.09
- RDY $13.42
- Analyst Decision
- HBI Hold
- RDY Buy
- Analyst Count
- HBI 5
- RDY 1
- Target Price
- HBI $5.20
- RDY $17.00
- AVG Volume (30 Days)
- HBI 6.4M
- RDY 2.2M
- Earning Date
- HBI 05-08-2025
- RDY 05-09-2025
- Dividend Yield
- HBI N/A
- RDY 0.71%
- EPS Growth
- HBI N/A
- RDY 1.46
- EPS
- HBI N/A
- RDY 0.79
- Revenue
- HBI $3,522,911,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- HBI $0.73
- RDY $10.38
- Revenue Next Year
- HBI $0.23
- RDY N/A
- P/E Ratio
- HBI N/A
- RDY $17.04
- Revenue Growth
- HBI 0.65
- RDY 16.61
- 52 Week Low
- HBI $4.02
- RDY $12.26
- 52 Week High
- HBI $9.10
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- HBI 55.11
- RDY 47.73
- Support Level
- HBI $4.65
- RDY $13.17
- Resistance Level
- HBI $5.25
- RDY $14.06
- Average True Range (ATR)
- HBI 0.17
- RDY 0.20
- MACD
- HBI 0.10
- RDY -0.07
- Stochastic Oscillator
- HBI 81.87
- RDY 27.78
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.